Chemically Defined Baculovirus Medium for Consistent Protein Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing insect cell culture media rely on undefined supplements like fetal bovine serum and yeast lysate, which are costly, variable in composition, and can contaminate cultures, complicating purification and increasing costs.

Innovation Solution

A chemically-defined, yeast hydrolysate-free medium is developed for insect cell culture, utilizing a baculovirus expression system with Sf9 cells and optional protein expression enhancers like HDAC inhibitors, along with cationic lipid or polymer-based transfection reagents for high-density growth and protein production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If chemically-undefined supplements like fetal bovine serum and yeast lysate are used in insect cell culture media, then cell growth and protein expression are supported, but composition variability and contamination risks increase

Engineering Contradiction:
Improvecell growth supportVSAvoidmedia composition consistency
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent applies parameter changes by transitioning from chemically-undefined supplements to a chemically-defined medium with precisely controlled parameters. The defined medium contains specific concentrations of amino acids (0.1-10 g/L), vitamins (10^-9 to 10^-3 g/L), and other components, eliminating batch-to-batch variability while maintaining cell growth support.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If chemically-undefined supplements like fetal bovine serum and yeast lysate are used in insect cell culture media, then cell growth is supported, but purification complexity and costs increase

Engineering Contradiction:
Improvecell growth supportVSAvoidpurification process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies the extraction principle by removing chemically-undefined supplements (fetal bovine serum, yeast lysate) from the culture medium. This elimination of complex, undefined components simplifies downstream purification processes and reduces contamination risks while maintaining cell growth through defined alternatives.

Inventive Principle:
Principle #2Taking out (Extraction)

3Quantity of substance

If chemically-undefined supplements are used in insect cell culture media, then nutritional requirements are met, but contamination with infectious agents occurs

Engineering Contradiction:
Improvenutrient availabilityVSAvoidinfectious agent contamination
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent applies this principle by replacing expensive, contamination-prone animal-derived supplements with affordable, chemically-defined components that can be sterilized and are free from infectious agents. The defined medium uses synthetic amino acids, vitamins, and other nutrients that eliminate biological contamination risks.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Reliability

If serum and yeast extract supplementation is used, then optimal culture conditions are achieved, but production costs increase

Engineering Contradiction:
Improveculture optimalityVSAvoidproduction cost
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent applies parameter changes by replacing expensive serum and yeast extract supplements with cost-effective chemically-defined components. The defined medium uses precisely controlled concentrations of amino acids, vitamins, and other nutrients at lower costs while maintaining optimal culture conditions and cell growth.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS12378575B2Chemically-defined baculovirus expression system
Publication Date: 2025.08.05 LIFE TECHNOLOGIES CORP
  • US12378575B2 patent drawing
  • US12378575B2 patent drawing
  • US12378575B2 patent drawing

AI summary

The present disclosure is related generally to systems and methods for high level expression of recombinant proteins from baculovirus in insect cells. In particular, the methods and systems described herein allow for high levels of baculovirus production in insect cells and/or high levels of protein production in insect cells using a chemically-defined, yeast lysate-free insect cell medium. The disclosure also relates to compositions and kits for culturing, transfecting, and/or producing recombinant protein in insect cells.